Clinical Trials | August 06, 2025
AbbVie announces positive Phase 3 results for Upadacitinib in Alopecia Areata
The average baseline SALT score was 83.8, indicating about 16% scalp hair coverage
The average baseline SALT score was 83.8, indicating about 16% scalp hair coverage
he new version features a streamlined sample-to-analysis workflow, built-in HRD detection, faster turnaround, and lower tissue requirements
The submission is supported by results from the Phase 3b APEX study
Fermenta now becomes one of the only two companies globally to hold a CEP for this variant of Vitamin D3
Prasad has played a key role in shaping Dr. Reddy’s into a globally respected organisation
The inspection was conducted from July 22-25, 2025
The coating is designed for heat-sealable applications, offering oil and grease resistance on kraft paper and suitable blister coatings for paper and paperboard
Based on the CRL, the STARGLO data do not provide sufficient evidence to support the proposed second-line DLBCL indication in the US patient population
This collaboration aims to bridge India’s talent and translational gap in this rapidly growing field by equipping professionals with practical expertise in the manufacturing of advanced therapies.
This achievement underscores our unwavering commitment to upholding the highest standards of quality, safety, and regulatory compliance
Subscribe To Our Newsletter & Stay Updated
